Art

J-GLOBAL ID：200902273590286077   Reference number：07A0515611

High-dose vitamins E and C supplementation prevents ribavirin-induced hemolytic anemia in patients with chronic hepatitis C

高用量ビタミンEおよびC補充療法は慢性C型肝炎患者におけるリバビリン誘発溶血性貧血を予防する

Author (14)： KAWAGUCHI Yasunori (Saga Medical School) ,  MIZUTA Toshihiko (Saga Medical School) ,  TAKAHASHI Kazuhiro (Saga Prefectural Hospital, Saga, JPN) ,  IWANE Shinji (Saga Prefectural Hospital, Saga, JPN) ,  ARIO Keisuke (Saga Medical School) ,  KAWASOE Hiroaki (Saga Medical School) ,  HAMAOKA Kazuhiro (Saga Medical School) ,  EGUCHI Yuichiro (Saga Medical School) ,  YASUTAKE Tsutomu (Saga Medical School) ,  SHIGEMATSU Hironao (Saga Prefectural Hospital, Saga, JPN) ,  KAWAZOE Seiji (Saga Prefectural Hospital, Saga, JPN) ,  FUKUSHIMA Noriko (Saga Medical School) ,  OZAKI Iwata (Saga Medical School) ,  FUJIMOTO Kazuma (Saga Medical School)
Material： Hepatology Research  (Hepatol Res)
Volume： 37  Issue： 5  Page： 317-324  Publication year： May. 2007 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0515611&from=J-GLOBAL&jstjournalNo=W1284A") }}

JST classification (2)： Vitamin E  (EB07060S) ,  Vitamin C  (EB07040W)

Substance index (2)： Ribavirin ,  Ascorbic Acid

Reference (23)：

• MCHUTCHISON, JG. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998, 339, 1485-1492
• DAVIS, GL. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med. 1998, 339, 1493-1499
• POYNARD, T. Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet. 1998, 352, 1426-1432
• MCHUTCHISON, JG. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterol. 2002, 123, 1061-1069
• TAKAKI, S. Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C. J Gastroenterol. 2004, 39, 668-673

Terms in the title (9)： 高用量 ,  ビタミンE ,  補充療法 ,  慢性C型肝炎 ,  患者 ,  リバビリン ,  誘発 ,  溶血性貧血 ,  予防